Tirofiban
Hydrochloride
Monohydrate

Tirofiban Hydrochloride Monohydrate as active pharmaceutical ingredient (API) is an agent which antagonize or impair any mechanism leading to blood platelet aggregation. Tirofiban Hydrochloride Monohydrate API prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. Tirofiban Hydrochloride Monohydrate API is used for treatment, in combination with heparin, of acute coronary syndrome. Tirofiban Hydrochloride Monohydrate comes as solution for injection.

Tirofiban Hydrochloride Monohydrate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Tirofiban Hydrochloride Monohydrate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Tirofiban Hydrochloride Monohydrate API is commercially available as standard grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Tirofiban Hydrochloride Monohydrate API.